This study investigates the use of Huaier Granule in patients who have undergone surgery for pancreatic cancer. The purpose of this study is to evaluate the potential benefits of Huaier Granule as an additional treatment after surgery.
The study will focus on assessing the effectiveness and safety of Huaier Granule. Researchers will look at how well patients respond to the treatment and monitor any side effects.
- Who can participate: Participants must be between 18 and 80 years old, have been diagnosed with pancreatic cancer after surgery, and should not have received any other treatments. They must also be willing to cooperate with study requirements.
- Study details: Participants will take part in one of two treatment groups. Some will receive standard chemotherapy, while others will take Huaier Granule.
- Study timelines: The study will last from April 2024 to March 2026.
How understandable was the trial content above?
Hard to understand
Easy to understand